Literature DB >> 15899565

Oral fluid collection: the neglected variable in oral fluid testing.

Dennis J Crouch1.   

Abstract

The potential to use oral fluid as a drug-testing specimen has been the subject of considerable scientific interest. The ease with which specimens can be collected and the potential for oral fluid (OF) drug concentrations to reflect blood-drug concentrations make it a potentially valuable specimen in clinical as well as forensic settings. However, the possible effects of the OF collection process on drug detection and quantification has often been over looked. Several studies have documented that drug-contamination of the oral cavity may skew oral fluid/blood drug ratios and confound interpretation when drugs are smoked, insufflated or ingested orally. OF pH is predicted to have an effect on the concentration of drugs in OF. However, in a controlled clinical study, the effect of pH was less than that of collection technique. Mean codeine OF concentrations in specimens collected a non-stimulating control method were 3.6 times higher than those in OF collected after acidic stimulation. Mean codeine concentrations were 50% lower than control using mechanical stimulation and 77% of control using commercial collection devices. Several factors should be considered if a commercial OF collection device is used. In vitro collection experiments demonstrated that the mean collection volume varied between devices from 0.82 to 1.86 mL. The percentage of the collected volume that could be recovered from the device varied from 18% to 83%. In vitro experiments demonstrated considerable variation in the recovery of amphetamines (16-59%), opiates (33-50%), cocaine and benzoylecgonine (61-97%), carboxy-THC (0-53%) and PCP (9-56%). Less variation in collection volume, volume recovered and drug recovery was observed intra-device. The THC stability was evaluated in a common commercial collection protocol. Samples in the collection buffer were relatively stable for 6 weeks when stored frozen. However, stability was marginal under refrigerated conditions and poor at room temperature. Very little has been published on the efficacy of using IgG concentration, or any other endogenous marker, as a measure of OF specimen validity. Preliminary rinsing experiments with moderate (50 mL and 2 x 50 mL) volumes of water did not reduce the OF IgG concentration below proposed specimen validity criteria. In summary, obvious and more subtle variables in the OF collection may have pronounced effects on OF-drug concentrations. This has rarely been acknowledged in the literature, but should to be considered in OF drug testing, interpretation of OF-drug results and future research studies.

Entities:  

Mesh:

Year:  2005        PMID: 15899565     DOI: 10.1016/j.forsciint.2005.02.028

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  27 in total

1.  A Case Study Evaluating the Efficacy of an Ad Hoc Hospital Collection Device for Fentanyl in Infant Oral Fluid.

Authors:  Ashley M Gesseck; Justin L Poklis; Carl E Wolf; Jie Xu; Aamir Bashir; Karen D Hendricks-Muñoz; Michelle R Peace
Journal:  J Anal Toxicol       Date:  2020-10-12       Impact factor: 3.367

2.  Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.

Authors:  Garry Milman; Allan J Barnes; David M Schwope; Eugene W Schwilke; Robert S Goodwin; Deana L Kelly; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2011-06-03       Impact factor: 4.142

3.  Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Authors:  Garry Milman; David M Schwope; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-01-20       Impact factor: 3.786

4.  Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.

Authors:  Dayong Lee; Garry Milman; David M Schwope; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-04-24       Impact factor: 8.327

Review 5.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

6.  Whole-saliva proteolysis and its impact on salivary diagnostics.

Authors:  K Thomadaki; E J Helmerhorst; N Tian; X Sun; W L Siqueira; D R Walt; F G Oppenheim
Journal:  J Dent Res       Date:  2011-09-13       Impact factor: 6.116

Review 7.  Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?

Authors:  Krishnan Chakravarthy; Aneesh Goel; George M Jeha; Alan David Kaye; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2021-02-17

8.  Evaluation of Correlation between Salivary Calcium, Alkaline Phosphatase and Osteoporosis- A Prospective, Comparative and Observational Study.

Authors:  Mainak Kanti Saha; Prerna Agrawal; Suparna Ganguly Saha; Vinod Vishwanathan; Vandana Pathak; Sakuru Venkata Saiprasad; Purvi Dhariwal; Mahendra Dave
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  Optimum methadone compliance testing: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-12-01

10.  Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.

Authors:  Sébastien Anizan; Mateus M Bergamaschi; Allan J Barnes; Garry Milman; Nathalie Desrosiers; Dayong Lee; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-07-03       Impact factor: 3.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.